Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-07-000290
Filing Date
2007-04-11
Accepted
2007-04-11 11:23:08
Documents
2
Period of Report
2007-04-11

Document Format Files

Seq Description Document Type Size
1 PRESS RELEASSE DATED APRIL 11, 2007 o35732e6vk.htm 6-K 15761
2 GRAPHIC o35732o3573200.gif GRAPHIC 2229
  Complete submission text file 0001130319-07-000290.txt   20405
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 07760443
SIC: 2834 Pharmaceutical Preparations